Literature DB >> 12890862

The Behcet's disease activity index.

G Lawton1, B B Bhakta, M A Chamberlain, A Tennant.   

Abstract

OBJECTIVE: To identify a subset of clinical features of Behçet's disease (BD) that can be summated to form an overall index of disease activity appropriate for clinical and research use internationally.
METHODS: Completed Behçet's Disease Current Activity Forms were collected from a total of 524 patients with BD from five countries. The data from 14 questions on the form were subjected to Rasch analysis to establish whether these items form a hierarchical and unidimensional scale of disease activity, both within and between countries.
RESULTS: The data showed a good fit to the Rasch model within three countries using a dichotomous scoring function. However, when the data from these three countries were pooled, the fit to the model was poor. Cross-cultural differential item functioning (DIF) was found in seven items in the pooled data. When the items with DIF by country were separated and two items were removed, the resulting 26-item scale showed a good fit to the Rasch model.
CONCLUSIONS: Within Turkey, Korea and the UK, the 14 items can be summated to give an index of disease activity. Analysis of the pooled data confirmed that the index is not suitable for comparison between countries or for pooling of data in the raw form, but after fitting the data to the Rasch model such comparisons can be made. This gives a scaling tool that is quick and easy to use in the clinical situation.

Entities:  

Mesh:

Year:  2003        PMID: 12890862     DOI: 10.1093/rheumatology/keg453

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  40 in total

1.  Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet's disease.

Authors:  Nuh Ataş; Hakan Babaoğlu; Ertuğrul Demirel; Bülent Çelik; Reyhan Bilici Salman; Hasan Satış; Hazan Karadeniz; Aslıhan Avanoğlu Güler; Seminur Haznedaroğlu; Berna Göker; Abdurrahman Tufan; Mehmet Akif Öztürk
Journal:  Eur J Rheumatol       Date:  2020-07-21

2.  Decreased protein S activity is related to the disease activity of Behcet's disease.

Authors:  Seong Ryul Kwon; Mie Jin Lim; Shin Goo Park; Yeon Sook Moon; Won Park
Journal:  Rheumatol Int       Date:  2006-09-13       Impact factor: 2.631

3.  Behçet's disease ocular attack score 24: evaluation of ocular disease activity before and after initiation of infliximab.

Authors:  Toshikatsu Kaburaki; Kenichi Namba; Koh-hei Sonoda; Takeshi Kezuka; Hiroshi Keino; Takako Fukuhara; Koju Kamoi; Kei Nakai; Nobuhisa Mizuki; Nobuyuki Ohguro
Journal:  Jpn J Ophthalmol       Date:  2014-01-31       Impact factor: 2.447

4.  Differential item functioning in the Observer Scale of the POSAS for different scar types.

Authors:  Martijn B A van der Wal; Wim E Tuinebreijer; Åsa Lundgren-Nilsson; Esther Middelkoop; Paul P M van Zuijlen
Journal:  Qual Life Res       Date:  2014-02-09       Impact factor: 4.147

Review 5.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

6.  The determination of matrix metalloproteinase 9 activity and gene expression levels in Behcet's disease patients with aneurysmal complications.

Authors:  Yasemin Aksoy; Ayse Ercan; Ozlem Dalmizrak; Hande Canpinar; Selda Pelin Kartal Durmazlar; Murat Bayazit
Journal:  Clin Rheumatol       Date:  2010-09-15       Impact factor: 2.980

Review 7.  Behcet's Syndrome.

Authors:  Sam R Dalvi; Resit Yildirim; Yusuf Yazici
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

8.  Accuracy of recall of the items included in disease activity forms of Behçet's disease: comparison of retrospective questionnaires with a daily telephone interview.

Authors:  Ismail Simsek; Coskun Meric; Hakan Erdem; Salih Pay; Selim Kilic; Ayhan Dinc
Journal:  Clin Rheumatol       Date:  2008-04-30       Impact factor: 2.980

9.  Serum levels of natriuretic peptides in patients with Behcet's disease.

Authors:  Ramazan Yağci; Yüksel Totan; Ekin Ozlük; Hüseyin Ozyurt; Gülfer Akbay; Meral Ekşioğlu
Journal:  Clin Rheumatol       Date:  2008-04-15       Impact factor: 2.980

10.  One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs.

Authors:  Annarita Giardina; Angelo Ferrante; Francesco Ciccia; Maria Vadalà; Ennio Giardina; Giovanni Triolo
Journal:  Rheumatol Int       Date:  2009-10-27       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.